HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maha Coucha Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

8/2019Modulating Expression of Thioredoxin Interacting Protein (TXNIP) Prevents Secondary Damage and Preserves Visual Function in a Mouse Model of Ischemia/Reperfusion.
3/2018Inducible overexpression of endothelial proNGF as a mouse model to study microvascular dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maha Coucha Research Topics

Disease

7Inflammation (Inflammations)
01/2022 - 01/2016
6Ischemia
08/2019 - 03/2015
5Stroke (Strokes)
05/2015 - 10/2012
4Hypoxia (Hypoxemia)
08/2019 - 08/2012
4Ischemic Stroke
08/2014 - 10/2012
3Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2016
2Blindness (Hysterical Blindness)
01/2020 - 01/2019
2Pathologic Neovascularization
01/2020 - 01/2019
2Neurodegenerative Diseases (Neurodegenerative Disease)
08/2019 - 03/2018
2Obesity
06/2017 - 02/2017
2Vascular Remodeling
11/2014 - 11/2014
1Cognitive Dysfunction
01/2022
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2020
1Vision Disorders (Hemeralopia)
08/2019
1Herpes Zoster
01/2019
1Albuminuria
03/2018
1Myocardial Infarction
03/2018
1Insulin Resistance
02/2017
1Hyperglycemia
08/2014
1Reperfusion Injury
12/2013
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2013
1Brain Ischemia (Cerebral Ischemia)
03/2013
1Vascular System Injuries
03/2013
1Edema (Dropsy)
03/2013

Drug/Important Bio-Agent (IBA)

5Retinaldehyde (Retinal)IBA
01/2020 - 02/2017
4Proteins (Proteins, Gene)FDA Link
08/2019 - 12/2013
4Peroxynitrous Acid (Peroxynitrite)IBA
05/2015 - 08/2012
3Glucose (Dextrose)FDA LinkGeneric
02/2017 - 03/2015
3salicylhydroxamic acid (SHAM)IBA
10/2016 - 12/2013
2Oxygen (Dioxygen)IBA
01/2020 - 10/2016
2Ephrin-B2 (Ephrin B2)IBA
01/2020 - 01/2019
2ThioredoxinsIBA
08/2019 - 02/2017
2InflammasomesIBA
08/2019 - 06/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2018 - 06/2017
23-nitrotyrosineIBA
10/2016 - 05/2015
2Endothelin Receptors (Endothelin Receptor)IBA
11/2014 - 10/2012
1Exenatide (Byetta)FDA Link
01/2022
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
01/2019
1Claudin-5IBA
01/2019
1LM11A-31IBA
01/2019
1Tight Junction ProteinsIBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2019
1Nerve Growth Factor (NGF)IBA
03/2018
1Tyrosine (L-Tyrosine)FDA Link
06/2017
1Butyric Acid (Butanoic Acid)IBA
02/2017
1Small Interfering RNA (siRNA)IBA
10/2016
1Actins (F Actin)IBA
10/2016
1LinagliptinIBA
01/2016
1Dipeptidyl-Peptidase IV InhibitorsIBA
01/2016
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2016
1Caspase 3 (Caspase-3)IBA
05/2015
1Metformin (Glucophage)FDA LinkGeneric
05/2015
1Protein Kinases (Protein Kinase)IBA
05/2015
1Phosphatidylinositols (Phosphatidylinositol)IBA
05/2015
1SolutionsIBA
03/2015
1Bosentan (Tracleer)FDA Link
11/2014
1azilsartanIBA
11/2014
1Angiotensin II Type 1 Receptor BlockersIBA
11/2014
1azilsartan medoxomilIBA
11/2014
1Blood Glucose (Blood Sugar)IBA
08/2014
1Minocycline (Cyclops)FDA LinkGeneric
03/2013
1Matrix Metalloproteinases (MMPs)IBA
03/2013
1Pharmaceutical PreparationsIBA
03/2013
1CurcuminIBA
03/2013
1Tissue Plasminogen Activator (Alteplase)FDA Link
03/2013
1Endothelins (Endothelin)IBA
10/2012

Therapy/Procedure

1Lasers (Laser)
06/2017
1Glycemic Control
11/2014
1Thrombolytic Therapy
08/2014
1Length of Stay
08/2014
1Therapeutics
03/2013